MedTrace Logo

The TackSHS Survey: a Pan-European Study on SHS

NCT02928536 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 11902

Last updated 2019-11-20

Study results available
· View outcomes & findings →

Summary

Within the TackSHS project (H2020 project grant agreement No 681040), we will conduct a European cross-sectional study, aiming at i) estimating prevalence and investigating determinants of smoking, e-cigarette use and exposure to SHS and to e-cigarette aerosol; ii) analyzing the attitudes, perceptions and behaviours of the adult European population towards policies to limit SHS exposure; iii) comparing selected smoking-related data between TackSHS and a previously conducted pan-European survey; iv) assessing mortality and morbidity from selected respiratory and cardiovascular diseases attributable to SHS exposure among adults and children in Europe; v) quantifying the economic burden associated to the exposure to SHS and e-cigarette aerosol in Europe. Overall, approximately 12,000 individuals aged 15 years or over will be enrolled in 12 different European countries (BG, DE, ES, FR, GR, IE, IT, LV, PL, PT, RO, UK). Surveys will be representative of the country-specific population in terms of sex, age, and socio-economic characteristics.

Conditions

  • Second Hand Tobacco Smoke

Interventions

OTHER

no intervention

This is an observational study. No intervention is considered

Sponsors & Collaborators

  • Institut Català d'Oncologia

    collaborator OTHER

  • European Commission

    collaborator OTHER

  • Mario Negri Institute for Pharmacological Research

    lead OTHER

Principal Investigators

  • Silvano Gallus, Sc.D · Istituto Di Ricerche Farmacologiche Mario Negri

Eligibility

Min Age
15 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-12-31
Primary Completion
2018-10-31
Completion
2018-10-31

Countries

  • Italy

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02928536 on ClinicalTrials.gov